| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.33 | 1e-14 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.3 | 6e-13 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.3 | 2e-12 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.26 | 4e-12 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.31 | 5e-12 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.28 | 1e-10 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.4 | 2e-10 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.28 | 5e-10 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.25 | 5e-09 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.25 | 5e-09 |